Tudor Investment Corp ET AL Makes New Investment in Aspen Aerogels, Inc. $ASPN

Key Points

• Tudor Investment Corp ET AL initiated a new position in Aspen Aerogels, buying 486,596 shares worth about $3.39 million and now owns roughly 0.59% of the company, while overall institutional ownership stands at about 97.64%.
• Aspen reported weak quarterly results, with EPS of ($0.34) missing the ($0.27) estimate and revenue of $41.34M (down 66.4% YoY
• Analysts are mixed: the consensus rating is "Hold" with an average target of $4.25, but several firms have cut targets recently and ratings range from Buy to Sell.

Tudor Investment Corp ET AL bought a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 486,596 shares of the construction company's stock, valued at approximately $3,387,000. Tudor Investment Corp ET AL owned approximately 0.59% of Aspen Aerogels as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of the company. Connors Investor Services Inc. boosted its position in Aspen Aerogels by 14.2% during the third quarter. Connors Investor Services Inc. now owns 40,167 shares of the construction company's stock worth $280,000 after purchasing an additional 5,000 shares in the last quarter. Penn Capital Management Company LLC raised its holdings in shares of Aspen Aerogels by 39.0% in the third quarter. Penn Capital Management Company LLC now owns 1,036,995 shares of the construction company's stock worth $7,225,000 after acquiring an additional 291,118 shares during the last quarter. Prelude Capital Management LLC acquired a new position in shares of Aspen Aerogels in the third quarter worth $70,000. Numerai GP LLC acquired a new position in shares of Aspen Aerogels in the third quarter worth $127,000. Finally, Millennium Management LLC raised its holdings in shares of Aspen Aerogels by 59.6% in the third quarter. Millennium Management LLC now owns 1,447,517 shares of the construction company's stock worth $10,075,000 after acquiring an additional 540,772 shares during the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently commented on ASPN shares. Zacks Research upgraded Aspen Aerogels from a "strong sell" rating to a "hold" rating in a research note on Thursday, January 15th. TD Cowen dropped their target price on Aspen Aerogels from $7.00 to $6.00 and set a "buy" rating for the company in a research note on Thursday, February 26th. Barclays dropped their target price on Aspen Aerogels from $4.00 to $3.00 and set an "underweight" rating for the company in a research note on Thursday, March 5th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Aspen Aerogels in a research note on Friday, March 27th. Finally, Roth Mkm dropped their target price on Aspen Aerogels from $6.00 to $3.00 and set a "buy" rating for the company in a research note on Thursday, February 26th. Three equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $4.25.

Aspen Aerogels Price Performance

Shares of NYSE ASPN opened at $3.34 on Friday. Aspen Aerogels, Inc. has a 1-year low of $2.30 and a 1-year high of $9.78. The business has a 50-day moving average of $3.39 and a 200-day moving average of $4.32. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.90 and a quick ratio of 3.29. The company has a market capitalization of $276.22 million, a price-to-earnings ratio of -0.70 and a beta of 2.90.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its earnings results on Wednesday, February 25th. The construction company reported ($0.34) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.07). Aspen Aerogels had a negative return on equity of 13.91% and a negative net margin of 143.69%.The company had revenue of $41.34 million during the quarter, compared to analysts' expectations of $44.25 million. During the same period in the previous year, the company earned $0.14 EPS. Aspen Aerogels's quarterly revenue was down 66.4% on a year-over-year basis. Aspen Aerogels has set its Q1 2026 guidance at -0.280--0.240 EPS. On average, equities analysts anticipate that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Aspen Aerogels Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company's product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.

Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.